Screener
Phibro Animal Health Corporation PAHC Business Segments
| Q4 '26 | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Business | ||||||
| Mineral Nutrition | $76.99M+20.0% | $73.42M+9.9% | $68.95M+9.0% | $62.99M+6.6% | $64.15M+3.4% | |
| Performance Products | $22.2M+0.6% | $18.9M-16.6% | $14.99M-9.7% | $17.45M-7.4% | $22.07M+12.7% | |
| Revenue by Product | ||||||
| Medicated Feed Additives And Others | $207.63M+0.5% | $205.79M+13.3% | $202.11M+34.4% | $195.2M+81.0% | $206.53M+77.0% | |
| Mineral Nutrition | $76.99M+20.0% | $73.42M+9.9% | $68.95M+9.0% | $62.99M+6.6% | $64.15M+3.4% | |
| Nutritional Specialties | $49.88M+5.3% | $46.81M+8.0% | $50.23M+9.4% | $48.15M+12.9% | $47.38M+10.6% | |
| Performance Products | $22.2M+0.6% | $18.9M-16.6% | $14.99M-9.7% | $17.45M-7.4% | $22.07M+12.7% | |
| Vaccines | $40.05M+3.8% | $38.63M+15.7% | $37.64M+13.5% | $40.11M+25.2% | $38.57M+20.6% | |
| Revenue by Geography | ||||||
| Asia Pacific | $32.52M-7.2% | $30.69M+8.7% | $19.77M+1.1% | $29.38M+101% | $35.03M+107% | |
| EMEA | $53.75M-6.7% | $44.47M+14.3% | $44.78M+37.4% | $44.94M+44.4% | $57.61M+77.8% | |
| Latin America And Canada | $90.22M+7.3% | $75.62M+6.9% | $87.6M+20.5% | $87.23M+22.6% | $84.07M+19.8% | |
| US | $220.25M+9.0% | $232.77M+10.9% | $221.76M+20.2% | $202.35M+41.0% | $201.99M+31.4% |
FAQ
- How does Phibro Animal Health Corporation break its business down?
- Phibro Animal Health Corporation (PAHC) reports revenue by business across 2 parts — Mineral Nutrition and Performance Products. Each is extracted from the segment footnotes and tracked over time.
- Where does Phibro Animal Health Corporation's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Phibro Animal Health Corporation's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
